Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | MAOB | P27338 | 2/20 | 0.56 |
| ▸ | XDH | P47989 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24055427 | 0.96 | MAOA (0.54) | ALOX5MAOAMAOBXDHALDH1A1 | |
| SCHEMBL30787959 | 0.96 | MAOA (0.54) | ALOX5MAOAMAOBXDHALDH1A1 | |
| SCHEMBL3320621 | 0.84 | ALOX5 (0.57) | ALOX5MAOAMAOBXDHALDH1A1 | |
| SCHEMBL8264987 | 0.82 | AR (0.56) | MAOAMAOBXDHESR2HDAC8 | |
| SCHEMBL769249 | 0.81 | ALDH1A1 (0.62) | MAOAMAOBALDH1A1KDM4EHPGD | |
| SCHEMBL14566193 | 0.81 | QDPR (0.60) | XDHLMNAESR2MAPTCYP11B1 | |
| SCHEMBL948906 | 0.80 | ALOX5 (0.57) | ALOX5MAOAMAOBALDH1A1KDM4E | |
| Hydrochloric Acid SCHEMBL5307083 | 0.79 | QDPR (0.58) | XDHLMNAESR2MAPTCYP11B1 | |
| SCHEMBL16158538 | 0.78 | USP7 (0.46) | MAOAMAOBXDHESR2MCL1 | |
| SCHEMBL28676109 | 0.78 | TRIM24 (0.50) | MAOAMAOBXDHALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12252496-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-03-18 | — | — | US | disclosed |
| US-20210206775-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-07-08 | — | — | US | disclosed |
| US-20210206775-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-07-08 | — | — | US | disclosed |
| CN-112218870-A | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | 株式会社半导体能源研究所 | 2021-01-12 | — | — | CN | disclosed |
| EP-2764866-A1 | Inhibitors of nedd8-activating enzyme | IP Gesellschaft für Management mbH (DE) | 2014-08-13 | — | — | EP | disclosed |
| WO-2013021309-A1 | INTERMEDIATE AND PROCESS FOR THE PREPARATION OF A SULFONAMIDE DERIVATIVE | PFIZER LIMITED (GB) | 2013-02-14 | — | — | WO | disclosed |
| EP-2010485-A1 | AZETIDINE DERIVATIVES AS G-PROTEIN COUPLED RECEPTOR (GPR119 ) AGONISTS | Prosidion Limited (GB) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007116230-A1 | AZETIDINE DERIVATIVES AS G-PROTEIN COUPLED RECEPTOR (GPR119 ) AGONISTS | PROSIDION LTD (GB) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007025575-A1 | O-HYDROXY- AND O-AMINO BENZAMIDE DERIVATIVES AS IKK2 INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2007-03-08 | — | — | WO | disclosed |
| CN-1208403-A | Compounds | BRITISH ASTRA PHARMACEUTICALS (GB) | 1999-02-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12252496-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | TPMT, POU5F1, CCND1 | ALOX5 359/4885MAOA 940/4885MAOB 749/4885 |
| US-20210206775-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | TPMT, POU5F1, CCND1 | ALOX5 359/4885MAOA 940/4885MAOB 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.